Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Viral Syndrome”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06541028
What this trial is testing

Reducing Stigma in People Who Inject Drugs (PWID) With HIV Using a Rapid Start Antiretroviral Therapy Intervention (ART)

Who this might be right for
HivDrug Use
Yale University 135
Testing effectiveness (Phase 2)Study completedNCT00001081
What this trial is testing

Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium

Who this might be right for
CryptosporidiosisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Large-scale testing (Phase 3)WithdrawnNCT00785967
What this trial is testing

Immune Responses in Patients Treated With Raltegravir

Who this might be right for
HIV Infections
McGill University Health Centre/Research Institute of the McGill University Health Centre
Not applicableStudy completedNCT00097006
What this trial is testing

Retrovirus Epidemiology Donor Study-II (REDS-II)

Who this might be right for
Acquired Immunodeficiency SyndromeBlood DonorsBlood Transfusion+10 more
National Heart, Lung, and Blood Institute (NHLBI)
Large-scale testing (Phase 3)Study completedNCT00625404
What this trial is testing

FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women

Who this might be right for
HIV Infections
FHI 360 2,120
Very early researchStudy completedNCT00389311
What this trial is testing

A Pilot Study for Toxicity Evaluation of HIV Rectal Microbicides

Who this might be right for
HIV Infections
Johns Hopkins University 12
Not applicableStudy completedNCT05092529
What this trial is testing

Psychological Impact of COVID-19 on Intensive Care Survivors

Who this might be right for
COVID-19Psychological DistressDepression+3 more
Royal Liverpool University Hospital 1,620
Testing effectiveness (Phase 2)Study completedNCT04339712
What this trial is testing

Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction

Who this might be right for
COVID-19Virus DiseasesMacrophage Activation Syndrome+1 more
Hellenic Institute for the Study of Sepsis 102
Early research (Phase 1)Study completedNCT00002107
What this trial is testing

A Phase I Study of Subcutaneously Administered Proleukin (Aldesleukin) in HIV-Infected Patients

Who this might be right for
HIV Infections
Chiron Corporation
Not applicableStudy completedNCT05799339
What this trial is testing

Optimizing CAB-LA as PrEP for Women Who Inject Drugs

Who this might be right for
HIV InfectionsOpioid UseTrauma, Psychological
Alexis Roth 144
Not applicableStudy completedNCT03669939
What this trial is testing

Toward Safer Opioid Prescribing for Chronic Pain in High Risk Populations

Who this might be right for
HIV DiseaseChronic Pain
Icahn School of Medicine at Mount Sinai 42
Post-approval studies (Phase 4)UnknownNCT05481177
What this trial is testing

Ivabradine for Long-Term Effects of COVID-19 With POTS Cohort

Who this might be right for
Long Haul COVIDPostural Orthostatic Tachycardia Syndrome
Uniformed Services University of the Health Sciences 250
Not applicableUnknownNCT00797381
What this trial is testing

Efficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia

Who this might be right for
HIV InfectionHemophilia A
Shanghai Public Health Clinical Center 100
Testing effectiveness (Phase 2)Study completedNCT00434512
What this trial is testing

Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers

Who this might be right for
AIDSHIV Infections
GlaxoSmithKline 180
Not applicableStudy completedNCT04499781
What this trial is testing

Adherence Connection for Counseling, Education, and Support (ACCESS) II

Who this might be right for
HIV Infections
NYU Langone Health 60
Not applicableStudy completedNCT00100581
What this trial is testing

Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07462767
What this trial is testing

Precision Microbiota Interventions for Senoreduction Trial

Who this might be right for
HIV InfectionsAlcohol DrinkingAging+1 more
Louisiana State University Health Sciences Center in New Orleans 160
Not applicableNot Yet RecruitingNCT07624123
What this trial is testing

Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women Living With HIV

Who this might be right for
Cervix CancerHIV InfectionsHPV Infection
UNC Lineberger Comprehensive Cancer Center 17,734
Not applicableStudy completedNCT02890459
What this trial is testing

Innovative Behavioral Economics Incentives Strategies for Health

Who this might be right for
HIV/AIDS
University of California, San Francisco 3,580
Large-scale testing (Phase 3)Study completedNCT00002359
What this trial is testing

A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega

Who this might be right for
HIV Infections
The Immune Response Corporation 3,000
Next Page